Department of Critical Care Medicine, Lanzhou University Second Hospital, Lanzhou, Gansu Province, China.
Department of Critical Care Medicine, Lanzhou University Second Hospital, Lanzhou, Gansu Province, China.
Am J Med Sci. 2019 Sep;358(3):182-190. doi: 10.1016/j.amjms.2019.04.025. Epub 2019 May 6.
We aimed to investigate the prognostic significance of central venous-arterial carbon dioxide tension to arterial-central venous oxygen content ratio (Pcv-aCO/Ca-cvO) combined with arterial lactate clearance rate (LCR) as early resuscitation goals in septic shock.
We enrolled 145 septic shock patients admitted to our department from March 2013 to May 2017 in this study. They all received an initial resuscitation therapy according to the Surviving Sepsis Campaign guideline, and were classified into 4 groups according to Pcv-aCO/Ca-cvO and LCR at 6 hours after resuscitation (T6): Group A: Pcv-aCO/Ca-cvO > 1.8, LCR < 30%; Group B: Pcv-aCO/Ca-cvO > 1.8, LCR ≥ 30%; Group C: Pcv-aCO/Ca-cvO ≤ 1.8, LCR < 30% and Group D: Pcv-aCO/Ca-cvO ≤ 1.8, LCR ≥ 30%. General demographics, hemodynamic parameters, metabolic parameters, Acute Physiology and Chronic Health Evaluation II scores, Sequential Organ Failure Assessment scores, length of intensive care unit stay and 28-day mortality were compared among groups.
Group D had the lowest Acute Physiology and Chronic Health Evaluation II and Sequential Organ Failure Assessment score at day 3, the shortest intensive care unit stay and the lowest 28-day mortality. Kaplan-Meier survival curves up to day 28 showed group D had the longest median survival time. Pcv-aCO/Ca-cvO and LCR at T6 were independent predictors of 28-day mortality. The area under ROC curve for Pcv-aCO/Ca-cvO combined with LCR was significantly greater than either Pcv-aCO/Ca-cvO or LCR alone (both P < 0.05).
Combination of Pcv-aCO/Ca-cvO ratio and LCR is better than either alone to predict the adverse outcomes in septic shock, and may provide useful information for assessing the adequacy of resuscitation in early-stage septic shock.
我们旨在研究中心静脉-动脉二氧化碳分压与动脉-中心静脉氧含量比(Pcv-aCO/Ca-cvO)联合动脉乳酸清除率(LCR)作为脓毒性休克早期复苏目标的预后意义。
本研究纳入了 2013 年 3 月至 2017 年 5 月期间我院收治的 145 例脓毒性休克患者。所有患者均根据《拯救脓毒症运动指南》接受初始复苏治疗,并根据复苏后 6 小时(T6)的 Pcv-aCO/Ca-cvO 和 LCR 将其分为 4 组:A 组:Pcv-aCO/Ca-cvO>1.8,LCR<30%;B 组:Pcv-aCO/Ca-cvO>1.8,LCR≥30%;C 组:Pcv-aCO/Ca-cvO≤1.8,LCR<30%;D 组:Pcv-aCO/Ca-cvO≤1.8,LCR≥30%。比较各组患者的一般人口统计学、血流动力学、代谢参数、急性生理学和慢性健康评估 II 评分、序贯器官衰竭评估评分、重症监护病房住院时间和 28 天死亡率。
第 3 天,D 组的急性生理学和慢性健康评估 II 评分和序贯器官衰竭评估评分最低,重症监护病房住院时间最短,28 天死亡率最低。截至第 28 天的 Kaplan-Meier 生存曲线显示 D 组中位生存时间最长。T6 时的 Pcv-aCO/Ca-cvO 和 LCR 是 28 天死亡率的独立预测因素。Pcv-aCO/Ca-cvO 联合 LCR 的 ROC 曲线下面积明显大于 Pcv-aCO/Ca-cvO 或 LCR 单独的曲线下面积(均 P<0.05)。
Pcv-aCO/Ca-cvO 比值与 LCR 联合预测脓毒性休克不良预后优于单独使用,可能为早期脓毒性休克复苏效果评估提供有用信息。